Reported Q1 2026 sales of $6.8 million, comparable to $7.0 million in Q1 2025. Net loss for the quarter was $11.3 million, driven by $4.8 million in non-cash stock compensation and a $4.1 million unrealized loss on equity investments. Maintained a strong liquidity position with $60.2 million in cash and securities at quarter-end, bolstered by subsequent receipts of $12.8 million in government grants and $48.6 million in equity proceeds. Inventory levels increased significantly to $22 million from $12.5 million at year-end 2025 to support production ramp-up. Reaffirmed full-year 2026 revenue guidance of $125 million, with $75 million to $95 million expected from federal government antimony contracts.